Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Marketing Surveillance of TETRAXIM in Korea
NCT01437423Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2011
- Primary completion
- Nov 2015
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis in diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by Sanofi. Started Jun 2011; status: completed.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on NCT01437423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437423.